An observational study in Septic Shock, sponsored by University Hospital, Strasbourg, France. Completed at 3 sites in France. Open to participants aged 18 Years to 85 Years. Per ClinicalTrials.gov, last updated 2012-06-01.
Sponsored by University Hospital, Strasbourg, France · Observational
Microparticles (MPs) result from plasma cell membrane remodeling and shedding after cell stimulation or apoptosis. MPs are know recognized as a pool of bioactive messengers with emerging role in pathophysiology of immune and cardiovascular diseases. MPs have been characterized during septic shock and may contribute to dissemination of pro-inflammatory and procoagulant mediators. This is a prospective observational study of circulating MPs and blood coagulation in 100 septic shock patients admitted in 3 tertiary hospitals medical ICU at baseline (D1), D2, D3, D4 and D7.
890 studies on the registry are indexed under Shock, Septic; 210 are open to participants now.
This study's enrollment of 100 is close to the median of 100 across 309 observational studies indexed under Shock, Septic.
Browse Shock, Septic studies →University Hospital, Strasbourg, France is the lead sponsor of 989 studies on the registry; 348 are open to participants now.
Counted across the registry records on this site, refreshed daily.
Patients with septic shock
Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.
Exclusion Criteria:
The record gives a start of May 2003 and a completion of Dec 2011. It does not say whether these dates are actual or estimated.
How these figures are worked out, and which studies are left out of them.
This study is completed, as verified in May 2012. You cannot join it, but the record below documents what was studied.
Get an email when the registry record changes — status, dates, results — or when someone posts here.
Sign in to followQuestions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.
Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.
Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.
University Hospital, Strasbourg, France →